Woodmont Investment Counsel LLC Reduces Position in UnitedHealth Group Incorporated (NYSE:UNH)

Woodmont Investment Counsel LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,101 shares of the healthcare conglomerate's stock after selling 2,791 shares during the period. Woodmont Investment Counsel LLC's holdings in UnitedHealth Group were worth $9,156,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the stock. NewSquare Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter valued at approximately $25,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $30,000. Promus Capital LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth about $32,000. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group during the third quarter valued at approximately $37,000. Finally, Pillar Financial Advisors LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $40,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the firm's stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.33% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

Several research firms recently issued reports on UNH. KeyCorp reiterated an "overweight" rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Cantor Fitzgerald restated an "overweight" rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Barclays reduced their target price on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research note on Friday, January 17th. Finally, Stephens boosted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a report on Thursday, December 5th. Twenty equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of "Buy" and a consensus price target of $629.32.

UnitedHealth Group Trading Down 0.6 %

Shares of UnitedHealth Group stock traded down $2.92 during mid-day trading on Tuesday, hitting $513.58. The stock had a trading volume of 3,014,727 shares, compared to its average volume of 4,091,387. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The firm has a market cap of $469.78 billion, a P/E ratio of 33.13, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The firm has a 50-day moving average of $509.10 and a two-hundred day moving average of $545.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter in the prior year, the company posted $5.83 earnings per share. UnitedHealth Group's revenue for the quarter was up 6.8% compared to the same quarter last year. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.64%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.